These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38836284)

  • 21. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports.
    Juneja D; Nasa P; Jain R; Singh O
    World J Diabetes; 2023 Aug; 14(8):1314-1322. PubMed ID: 37664476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium-Glucose Cotransporter 2 Inhibitors, All-Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta-Analysis and Meta-Regression.
    Odutayo A; da Costa BR; Pereira TV; Garg V; Iskander S; Roble F; Lalji R; Hincapié CA; Akingbade A; Rodrigues M; Agarwal A; Lawendy B; Saadat P; Udell JA; Cosentino F; Grant PJ; Verma S; Jüni P
    J Am Heart Assoc; 2021 Sep; 10(18):e019918. PubMed ID: 34514812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comment on "Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients".
    Lai SW
    Cardiovasc Drugs Ther; 2024 Feb; 38(1):201-202. PubMed ID: 38008854
    [No Abstract]   [Full Text] [Related]  

  • 24. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report.
    Alkatheeri A; Alseddeeqi E
    J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals.
    Ishibashi Y; Matsui T; Yamagishi SI
    Diab Vasc Dis Res; 2016 Nov; 13(6):438-441. PubMed ID: 27407083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report.
    Vadasz B; Arazi M; Shukha Y; Koren O; Taher R
    J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stellate ganglion block reduces inflammation and improves neurological function in diabetic rats during ischemic stroke.
    Li TT; Wan Q; Zhang X; Xiao Y; Sun LY; Zhang YR; Liu XN; Yang WC
    Neural Regen Res; 2022 Sep; 17(9):1991-1997. PubMed ID: 35142688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
    Yii ESS; Azli AW; Sitaram PN
    J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke.
    Al Hamed FA; Elewa H
    Clin Ther; 2020 Nov; 42(11):e242-e249. PubMed ID: 33008610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.
    Klinkner G; Steingraber-Pharr M
    AACN Adv Crit Care; 2023 Mar; 34(1):27-32. PubMed ID: 36877649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium-glucose Cotransporter Type 2 Inhibitors: A New Insight into the Molecular Mechanisms of Diabetic Nephropathy.
    Li N; Zhou H
    Curr Pharm Des; 2022; 28(26):2131-2139. PubMed ID: 35718973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-of-the-Art Review.
    Gitto M; Vrachatis DA; Condorelli G; Papathanasiou K; Reimers B; Deftereos S; Stefanini GG
    Cardiovasc Hematol Agents Med Chem; 2022; 20(2):90-102. PubMed ID: 34370645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy.
    Balcıoğlu AS; Çelik E; Şahin M; Göçer K; Aksu E; Aykan AÇ
    Anatol J Cardiol; 2022 Nov; 26(11):832-840. PubMed ID: 35949125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac arrest from acute myocardial infarction complicated with sodium-glucose cotransporter 2 inhibitor-associated ketoacidosis.
    Dai Z; Nishihata Y; Kawamatsu N; Komatsu I; Mizuno A; Shimizu M; Toya N; Ishimatsu S; Komiyama N
    J Cardiol Cases; 2017 Feb; 15(2):56-60. PubMed ID: 30546697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sodium-glucose cotransporter-2 inhibitors on nutritional status in heart failure with reduced ejection fraction.
    Arslan K; Yılmaz E; Aydın E
    Rev Assoc Med Bras (1992); 2022; 68(11):1576-1581. PubMed ID: 36449777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Kidney Protection to Stroke Prevention: The Potential Role of Sodium Glucose Cotransporter-2 Inhibitors.
    Hsieh CY; Sung SF
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
    Fukuyama Y; Numata K; Yoshino K; Santanda T; Funakoshi H
    Acute Med Surg; 2020; 7(1):e480. PubMed ID: 31988792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.
    van Bommel EJM; Muskiet MHA; Tonneijck L; Kramer MHH; Nieuwdorp M; van Raalte DH
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):700-710. PubMed ID: 28254770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care.
    Fralick M; Schneeweiss S; Redelmeier DA; Razak F; Gomes T; Patorno E
    Diabetes Obes Metab; 2021 Oct; 23(10):2320-2328. PubMed ID: 34169619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.